Literature DB >> 3417352

Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora.

K H Wilson1, F Perini.   

Abstract

The cecal flora of mice is able to eliminate Clostridium difficile from the mouse cecum even when C. difficile is the first organism established. We used a continuous-flow (CF) culture model of the cecal flora to investigate the possibility that competition for nutrients is one mechanism for this antagonism. The medium for the CF cultures consisted of homogenates of fecal pellets from germfree mice. Carbohydrate analysis showed that mouse flora depleted 74 to 99.8% of the various carbohydrates from this environment-simulating medium. When inoculated into filtrates made from CF cultures of mouse flora, C. difficile multiplied slower than the dilution rate of the CF cultures unless glucose, N-acetylglucosamine, or N-acetylneuraminic acid was added. C. difficile did not synthesize hydrolytic enzymes able to cleave these monosaccharides from oligosaccharide side chains. As found previously, veal infusion broth did not support the growth of a microflora that could be transferred to gnotobiotic mice and fully suppress C. difficile. When mucin or monosaccharides found in mucin were added to veal infusion broth, the flora functioned normally in this regard. These data suggest that as yet unidentified organisms compete more efficiently than C. difficile for monomeric glucose, N-acetylglucosamine, and sialic acids found in colonic contents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3417352      PMCID: PMC259619          DOI: 10.1128/iai.56.10.2610-2614.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. I. Correlation between various tests.

Authors:  D J HENTGES; R FRETER
Journal:  J Infect Dis       Date:  1962 Jan-Feb       Impact factor: 5.226

2.  Polyacrylamide slab gel electrophoresis of soluble proteins for studies of bacterial floras.

Authors:  W E Moore; D E Hash; L V Holdeman; E P Cato
Journal:  Appl Environ Microbiol       Date:  1980-04       Impact factor: 4.792

Review 3.  Behavior of mixed cultures of microorganisms.

Authors:  A G Fredrickson
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

4.  Bacterial degradation of gastrointestinal mucins. I. Comparison of mucus constituents in the stools of germ-free and conventional rats.

Authors:  L C Hoskins; N Zamcheck
Journal:  Gastroenterology       Date:  1968-02       Impact factor: 22.682

5.  Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster.

Authors:  K H Wilson; J N Sheagren; R Freter
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

6.  Role of volatile fatty acids in colonization resistance to Clostridium difficile.

Authors:  R D Rolfe
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Survival and implantation of Escherichia coli in the intestinal tract.

Authors:  R Freter; H Brickner; J Fekete; M M Vickerman; K E Carey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Continuous-flow cultures as in vitro models of the ecology of large intestinal flora.

Authors:  R Freter; E Stauffer; D Cleven; L V Holdeman; W E Moore
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis.

Authors:  K H Wilson; J Silva; F R Fekety
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

10.  Role of competition for substrate in bacterial antagonism in the gut.

Authors:  H F Guiot
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more
  86 in total

Review 1.  Perspectives on bifidobacteria as biotherapeutic agents in gastrointestinal health.

Authors:  L C Duffy; A Leavens; E Griffiths; D Dryja
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Coming full circle: From antibiotics to probiotics and prebiotics.

Authors:  John M Conly; Lynn B Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-05       Impact factor: 2.471

Review 3.  Probiotics in human medicine.

Authors:  R Fuller
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

4.  Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile.

Authors:  S Karlsson; A Lindberg; E Norin; L G Burman; T Akerlund
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Pathogen Colonization Resistance in the Gut and Its Manipulation for Improved Health.

Authors:  Joseph M Pickard; Gabriel Núñez
Journal:  Am J Pathol       Date:  2019-05-14       Impact factor: 4.307

Review 6.  The Intersection Between Colonization Resistance, Antimicrobial Stewardship, and Clostridium difficile.

Authors:  Rossana Rosa; Curtis J Donskey; L Silvia Munoz-Price
Journal:  Curr Infect Dis Rep       Date:  2018-06-07       Impact factor: 3.725

7.  Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

8.  Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance.

Authors:  Jessica A Ferreyra; Katherine J Wu; Andrew J Hryckowian; Donna M Bouley; Bart C Weimer; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2014-12-10       Impact factor: 21.023

9.  Co-opting the Lap System of Pseudomonas fluorescens To Reversibly Customize Bacterial Cell Surfaces.

Authors:  T Jarrod Smith; Holger Sondermann; George A O'Toole
Journal:  ACS Synth Biol       Date:  2018-10-16       Impact factor: 5.110

10.  Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.

Authors:  Eric J Battaglioli; Vanessa L Hale; Jun Chen; Patricio Jeraldo; Coral Ruiz-Mojica; Bradley A Schmidt; Vayu M Rekdal; Lisa M Till; Lutfi Huq; Samuel A Smits; William J Moor; Yava Jones-Hall; Thomas Smyrk; Sahil Khanna; Darrell S Pardi; Madhusudan Grover; Robin Patel; Nicholas Chia; Heidi Nelson; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.